HomeIMMX • NASDAQ
add
Immix Biopharma Inc
Previous close
$1.68
Day range
$1.60 - $1.79
Year range
$1.26 - $7.75
Market cap
49.14M USD
Avg Volume
111.34K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.39M | 63.47% |
Net income | -7.15M | -67.02% |
Net profit margin | — | — |
Earnings per share | -0.24 | -4.35% |
EBITDA | -7.39M | -63.40% |
Effective tax rate | -0.16% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 19.69M | 0.55% |
Total assets | 25.14M | 11.87% |
Total liabilities | 7.59M | 168.65% |
Total equity | 17.55M | — |
Shares outstanding | 27.51M | — |
Price to book | 2.62 | — |
Return on assets | -68.50% | — |
Return on capital | -84.76% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -7.15M | -67.02% |
Cash from operations | -4.04M | -30.76% |
Cash from investing | -271.54K | -597.84% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -4.28M | -161.84% |
Free cash flow | -1.48M | 31.54% |
About
Founded
2012
Headquarters
Website
Employees
14
